ALCAM and cancer: By comparing the differential capacity of immobilized ALCAM+ and ALCAM− EVs to support the adhesion of wild-type (ALCAM+) and ALCAM-KO (ALCAM−) SKOV-3 and Colo-320 cells, we established that ALCAM/CD166 is involved in EV interactions with recipient cancer cells.